ATE453622T1 - Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren - Google Patents

Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren

Info

Publication number
ATE453622T1
ATE453622T1 AT07727328T AT07727328T ATE453622T1 AT E453622 T1 ATE453622 T1 AT E453622T1 AT 07727328 T AT07727328 T AT 07727328T AT 07727328 T AT07727328 T AT 07727328T AT E453622 T1 ATE453622 T1 AT E453622T1
Authority
AT
Austria
Prior art keywords
aryl
carboxylic acids
heteroaryl carboxylic
cyclic beta
enantiomeric enriched
Prior art date
Application number
AT07727328T
Other languages
English (en)
Inventor
Stephan Bachmann
Michelangelo Scalone
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE453622T1 publication Critical patent/ATE453622T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
AT07727328T 2006-04-03 2007-03-26 Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren ATE453622T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06112171 2006-04-03
PCT/EP2007/052855 WO2007113155A1 (en) 2006-04-03 2007-03-26 Process for preparation of enantiomerically enriched cyclic β-aryl or heteroaryl carboxylic acids

Publications (1)

Publication Number Publication Date
ATE453622T1 true ATE453622T1 (de) 2010-01-15

Family

ID=36992822

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727328T ATE453622T1 (de) 2006-04-03 2007-03-26 Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren

Country Status (15)

Country Link
US (3) US20070232653A1 (de)
EP (1) EP2029541B1 (de)
JP (1) JP5038392B2 (de)
KR (1) KR101087805B1 (de)
CN (1) CN101460461B (de)
AT (1) ATE453622T1 (de)
AU (1) AU2007233814B2 (de)
BR (1) BRPI0709880A2 (de)
CA (1) CA2648246C (de)
DE (1) DE602007004111D1 (de)
ES (1) ES2335710T3 (de)
IL (1) IL194219A (de)
MX (1) MX2008012566A (de)
TW (1) TWI356820B (de)
WO (1) WO2007113155A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010519272A (ja) * 2007-02-20 2010-06-03 ソルヴィーアス アクチェンゲゼルシャフト 不斉水素化反応で使用されるビス(フェロセニルホスフィノ)フェロセン配位子
EP2379500A1 (de) * 2008-12-16 2011-10-26 F. Hoffmann-La Roche AG Verfahren zur herstellung von pyrrolidin-3-carbonsäuren
DK2379491T3 (da) * 2008-12-18 2013-04-08 Hoffmann La Roche Fremgangsmåde til syntese af amino-methyl-tetralinderivater
JP6551922B2 (ja) * 2015-04-13 2019-07-31 国立大学法人名古屋大学 カルボン酸化合物の水素化によるアルコールの製造方法、及び該製造方法に用いるルテニウム錯体
US12365689B2 (en) 2015-10-16 2025-07-22 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US10550126B2 (en) 2015-10-16 2020-02-04 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11512092B2 (en) 2015-10-16 2022-11-29 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
KR20250010141A (ko) 2015-10-16 2025-01-20 애브비 인코포레이티드 (3S,4R)-3-에틸-4-(3H-이미다조[1,2-a]피롤로[2,3-e]-피라진-8-일)-N-(2,2,2-트리플루오로에틸)피롤리딘-1-카복스아미드및 이의 고체상 형태의 제조 방법
US11365198B2 (en) 2015-10-16 2022-06-21 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11780848B2 (en) 2015-10-16 2023-10-10 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof
US11524964B2 (en) 2015-10-16 2022-12-13 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
CA3082558A1 (en) * 2017-11-16 2019-05-23 Syngenta Participations Ag Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides
CN113185440B (zh) * 2021-05-13 2022-04-29 南京德克瑞医药化工有限公司 一种医药中间体n-boc-3-吡咯啉的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004058A (en) * 1954-09-21 1961-10-10 Callery Chemical Co Separation of trimethyl borate from the trimethyl borate-methanol azeotrope
DK350383A (da) * 1982-08-27 1984-02-28 Hoffmann La Roche Phosphorforbindelser
EP0190496A3 (de) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidinderivate mit gastro-intestinaler Wirkung
ATE128140T1 (de) * 1989-05-18 1995-10-15 Hoffmann La Roche Phosphorverbindungen.
DE59206900D1 (de) * 1991-03-15 1996-09-19 Hoffmann La Roche Diphosphonsaurederivate als zwischenprodukte zur herstellung von diphosphinliganden
US5721251A (en) * 1993-12-10 1998-02-24 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
FR2722194B1 (fr) * 1994-07-06 1996-08-23 Adir Nouveaux derives de benzopyrane, leur procede de preparation et les compositions pharmacuetiques qui les contiennent
JPH0873400A (ja) * 1994-09-01 1996-03-19 Sumitomo Chem Co Ltd 光学活性シクロプロパンカルボン酸誘導体の製造法
US5804578A (en) * 1996-04-03 1998-09-08 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5891882A (en) * 1996-12-06 1999-04-06 Abbott Laboratories Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
GB9924855D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel processes
US6545165B1 (en) * 2000-02-04 2003-04-08 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
FR2812638B1 (fr) * 2000-08-03 2003-04-25 Ppg Sipsy Utilisation de diphosphines chirales comme ligands optiquement actifs pour la preparation de complexes diphosphino-metalliques, les complexes ainsi obtenus et les procedes de catalyse asymetrique les mettant en oeuvre
US7262303B2 (en) * 2003-09-29 2007-08-28 Hoffman-La Roche Inc. Process for the production of chiral propionic acid derivatives
JPWO2005068427A1 (ja) * 2004-01-14 2007-09-06 武田薬品工業株式会社 カルボキサミド誘導体およびその用途
US7138423B2 (en) * 2004-07-20 2006-11-21 Bristol-Myers Squibb Company Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
GB0510810D0 (en) * 2005-05-26 2005-06-29 Novartis Ag Organic compounds
WO2007016431A2 (en) * 2005-07-29 2007-02-08 Concert Pharmaceuticals Inc. Novel benzo [d] [1,3]-dioxol derivatives

Also Published As

Publication number Publication date
AU2007233814B2 (en) 2012-08-16
US20070232653A1 (en) 2007-10-04
US20130253201A1 (en) 2013-09-26
BRPI0709880A2 (pt) 2011-07-26
EP2029541A1 (de) 2009-03-04
ES2335710T3 (es) 2010-03-31
KR20080100283A (ko) 2008-11-14
CN101460461A (zh) 2009-06-17
DE602007004111D1 (de) 2010-02-11
KR101087805B1 (ko) 2011-11-29
CN101460461B (zh) 2012-10-03
TW200806628A (en) 2008-02-01
IL194219A (en) 2012-06-28
JP5038392B2 (ja) 2012-10-03
CA2648246C (en) 2014-02-18
EP2029541B1 (de) 2009-12-30
CA2648246A1 (en) 2007-10-11
JP2009532410A (ja) 2009-09-10
US20110105758A1 (en) 2011-05-05
MX2008012566A (es) 2008-10-10
TWI356820B (en) 2012-01-21
WO2007113155A1 (en) 2007-10-11
AU2007233814A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
ATE453622T1 (de) Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren
ATE517190T1 (de) Verfahren zur fermentativen herstellung von 1,5- diaminopentan
EA201001445A1 (ru) ПОЛУЧЕНИЕ 6-АМИНОКАПРОНОВОЙ КИСЛОТЫ ИЗ α-КЕТОПИМЕЛИНОВОЙ КИСЛОТЫ
EA201001444A1 (ru) Синтез эфиров или тиоэфиров адипата
ATE512990T1 (de) Verfahren zur herstellung von gereinigten beta-(1,3)-d-glucanen
ATE443757T1 (de) L-aminosäure produzierender mikroorganismus und verfahren zur l-aminosäureproduktion
DE602004008183D1 (de) Verfahren zur Herstellung von L-Cystein unter Verwendung eines zur Gattung Escherichia gehörenden Bakteriums
DE602005011609D1 (de) Verbessertes verfahren zur herstellung von 3-hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen
MX2010012698A (es) Proceso para la hidrolisis enzimatica estereoselectiva del ester del acido 5-metil-3-nitro-metil-hexanoico.
WO2013011292A3 (en) Microorganism for converting carbon dioxide to aliphatic carboxylic acids via formic acid intermediate
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE437953T1 (de) Verfahren zur herstellung von calcium-d- panthothenat
ATE438649T1 (de) Verfahren zur herstellung von dorzolamid
TW200801197A (en) Methods for production of dioic acids
ATE550944T1 (de) Pilzstämme und ein verfahren zur herstellung eines insektizids von diesen stämmen
ATE473955T1 (de) Verfahren zur herstellung von angereichertem isopulegol
ATE446374T1 (de) Verfahren zur enantioselektiven enzymatischen reduktion von ketoverbindungen
EP1727778A4 (de) Verfahren zur herstellung von xylit
ATE424392T1 (de) Verfahren zur herstellung von enantiomerenreinen aminoalkoholen
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
ATE537148T1 (de) Verfahren zur herstellung eines azabicycloalkanolderivats
ATE457356T1 (de) Verfahren zur herstellung von vorwiegend ein enantiomer enthaltendes 1,1,1-trifluorisopropanol
ATE540017T1 (de) Verfahren zur herstellung von estern
ATE517890T1 (de) Verfahren zur herstellung von reinem irbesartan

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2029541

Country of ref document: EP